Importantly, tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
In addition to low L-carnitine (due to a heterozygote transporter mutation), elevated 3-methylhistidine was present, suggesting elevated muscle breakdown
Last week, the US Food and Drug Administration announced that tirzepatide is no longer in shortage
How to Build a Skin-Supportive Routine If you are looking to support your skin from the inside out, consistency is more important than intensity
No pharmacokinetic interaction with rosuvastatin is known, making CoQ10 a reasonable pairing with both rosuvastatin and vitamin D
Adeem Azhar, MPharm, IPres Co-Founder and Chief Executive Officer Core Prescribing Solutions Qualified Clinical Pharmacist What does this mean for GP practices and PCNs